Private equity firms are grappling with a growing class of companies that neither grow nor fail, clogging funds and delaying investor payouts. The issue has gained urgency as higher interest rates, slower deal exits, and debt burdens trap assets in extended holding periods that were once rare. The problem spans geographies and sectors, affecting funds raised during the boom years and challenging the industry’s promise of steady returns and swift exits.
Background: From Easy Money to Exit Drought
For much of the past decade, low borrowing costs supported high purchase prices and rapid refinancing. Firms could buy, add debt, and sell or list companies within a few years. That cycle is now strained. Financing is more expensive, public markets are choosier, and strategic buyers are cautious. Many companies acquired on optimistic forecasts are meeting slower demand and tighter margins.
In this environment, managers face portfolio companies that cover interest costs but struggle to pay down debt or fund growth. These assets linger, tying up capital and complicating performance metrics for funds nearing the end of their terms.
“Private equity firms are facing a new reality: a growing crop of companies that can neither thrive nor die, lingering in portfolios like the undead.”
Funds Stretch Timelines and Seek Workarounds
To manage aging assets, firms have leaned on extensions and new structures. Fund lives are being lengthened to avoid forced sales at weak prices. Some managers set up continuation vehicles to roll select companies into new funds, offering fresh time and capital to work through operational fixes.
Secondary markets have become a pressure valve. Limited partners who want liquidity are selling stakes to specialized buyers, often at discounts. This reduces immediate strain but moves the timing challenge to new investors who expect clearer plans and tighter oversight.
Operational Fixes Take Center Stage
With capital more costly, value creation now rests more on execution than financial engineering. Firms are pushing performance plans focused on cash and cost control. Management teams face closer targets, shorter review cycles, and sharper trade-offs on investment.
- Cutting nonessential spending and renegotiating supplier contracts.
- Refinancing debt where possible to spread maturities.
- Shifting pricing strategies and focusing on higher-margin products.
- Exploring asset sales to reduce leverage.
These steps can stabilize a stalemated company, but they are slow and carry risk if markets weaken again or if demand fails to recover.
Investor Patience and Performance Pressures
The shift tests investor patience. Pension funds and endowments rely on periodic distributions to fund commitments across asset classes. Delays can create an allocation squeeze and reduce appetite for new PE commitments. Managers, in turn, must balance the optics of write-downs with the need for realism.
Fees also come into focus. Longer holds can increase management fee burdens on aging assets, drawing scrutiny from investors who prefer that underperformers be sold, merged, or wound down. Transparency around valuation marks, exit timing, and use of financing tools is now a key demand in limited partner meetings.
Market Signals and What Comes Next
Some green shoots exist. If inflation cools and borrowing costs ease, buyers may return and valuations may stabilize. Strategic acquirers with strong balance sheets could reenter deal talks where synergies are clear. A modest reopening of the IPO window would also help, especially for companies with steady cash flow and clean stories.
Still, many assets will need more than time. Companies bought on peak multiples or with aggressive growth cases may face restructurings, leadership changes, or partial sales. Firms with disciplined underwriting and strong operating playbooks appear better positioned to work through the backlog.
Balanced Outlook: Discipline Over Deal Volume
The industry is moving from rapid turnover to a grind built on cash flow, cost discipline, and selective exits. That demands different skills and expectations. It also favors managers who can separate salvageable assets from those that must be sold or merged to free capital.
The “undead” label captures the frustration. But it also points to a clear task: restore health where possible and accept losses where not. Investors will watch how managers make those calls and how quickly distributions resume.
For now, the key markers are straightforward: steadier rates, credible exit markets, and hard choices on underperformers. If those improve, the backlog should thin. If not, the industry will need more time, more transparency, and more operational lift to bring portfolios back to life.